Navigation Links
Lamotrigine May Reduce Epilepsy Seizures
Date:10/16/2007

Adding it to existing regimen may help, researchers say

TUESDAY, Oct. 16 (HealthDay News) -- When taken once a day as an added therapy, the epilepsy drug lamotrigine is effective in controlling partial seizures, an international study finds.

The 239 participants, aged 13 and older, were recruited from the United States and several other countries. They were already taking one or two medications, but these did not fully control their partial seizures.

The patients received either lamotrigine in extended-release formula or a placebo for 19 weeks. They continued taking their other epilepsy medications.

Patients who had lamotrigine added to their therapy had 46 percent fewer seizures during the study, compared to 24 percent fewer seizures among patients taking the placebo. The study also found that 42 percent of the patients who took the drug had reduced seizure frequency by the end of the study, compared with 24 percent of those who took the placebo.

The study, published in the Oct. 16 issue of the journal Neurology, was sponsored and conducted by drug maker GlaxoSmithKline, which markets lamotrigine as Lamictal.

"This new once daily medication may be an important option for people with epilepsy that could significantly increase their compliance with prescribed treatment," study author Dr. Dean Naritoku, of Southern Illinois University in Springfield, said in a prepared statement.

Patients need to take their medication reliably and consistently in order to maintain stable blood levels of epilepsy drugs and good control of seizures.

"The more often people have to remember to take their medication each day, the more likely they are to miss a dose. Once-a-day dosing is more convenient for patients," Naritoku said.

More information

The Epilepsy Foundation has more about epilepsy medications.



-- Robert Preidt



SOURCE: American Academy of Neurology, news release, Oct. 15, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Epilepsy Drug Valproate and Lamotrigine Linked To Malformed Fetus
2. Stress reduces your immunity- startling but true!!!!!
3. Risk of Cancer can be reduced to 40% with a High Fiber Diet
4. Thirty minutes of work up per day reduces the risk of Diabetes
5. Vaccine Reduces antibiotic-resistant infections in Children
6. Drugs said to Reduce HIV Transmission to Baby
7. Mentally Demanding Jobs Found To Reduce The Risk Of Alzheimer’
8. Vitamin D Reduces Chances of Colon, Breast And Ovarian Cancers by 50%
9. Aspirin reduces deaths
10. Stop smoking and reduce weight
11. Statins reduce heart attacks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... , Oct. 4, 2017 OBP ... self-contained, illuminating medical devices, today announced regulatory approval ... Surveillance Agency (or Agência Nacional de Vigilância Sanitária ... single-use, cordless surgical retractor with integrated LED light ... access, illumination and exposure of a tissue pocket ...
(Date:10/2/2017)... -- The Rebound mobile app is poised to become a ... of prescription drug addiction. The app empowers users to develop ... down their dosage in a safe, controlled manner while maximizing ... first 100,000 people to sign up will enjoy 3 months ... ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
Breaking Medicine Technology: